Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 4503 (miR-4503; hsa-mir-4503) is a member of the microRNA (miRNA) family, which are small non-coding RNAs that modulate gene expression at the post-transcriptional level by binding to complementary sequences in target messenger RNAs (mRNAs), thereby influencing translation or promoting mRNA degradation[1][4][3]. Like other miRNAs, it is presumed to play a regulatory role in cellular processes, but there is insufficient evidence in current public databases and biomedical literature to suggest that miR-4503 is a well-characterized therapeutic target, biomarker, or has known drug interactions. There is also little functional or disease association information publicly available specific to miR-4503, making it likely that this target is either very poorly characterized or that the entry may be incorrect or spurious.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 4503 (miR-4503).